Trials / Completed
CompletedNCT06009484
VTE Incidence After Curative Colon Cancer Surgery in an ERAS Program
Incidence of Venous Thrombotic Event After Curative Colon Cancer Surgery in an Enhanced Recovery After Surgery Program
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,141 (actual)
- Sponsor
- Nordsjaellands Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Based on data on a cohort of 2,141 patients undergoing elective colonic cancer resection in an ERAS program, the incidence of postoperative thromboembolic events is estimated in patients no receiving prolonged thromboembolic prophylaxis.
Detailed description
The Copenhagen cOmplete Mesocolic Excision Study (COMES) database contains comprehensive data on preoperative, intraoperative, postoperative and tumor related variable on patients undergoing elective colonic cancer resection at four public university clinics providing all colorectal cancer treatment for the 1.8 million residents of the Capital Region of Denmark during the period 2014-2017. None of these hospitals had implemented prolonged thromboembolic prophylaxis after discharge. The medical records were reviewed with focusing on VTE prophylaxis, ongoing preoperative and postoperative anticoagulant treatment, the length of hospital stay (LOS), and readmission to ensure high data validity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Colon resection | Colon cancer resection |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2017-12-31
- Completion
- 2018-03-15
- First posted
- 2023-08-24
- Last updated
- 2023-08-24
Source: ClinicalTrials.gov record NCT06009484. Inclusion in this directory is not an endorsement.